Dr K Narayana Raju

The questions about when to return to work and when to drive are among the most practical and most important that patients ask after coronary intervention, and the answers depend on the nature of the procedure performed, the type of work, and whether a heart attack with any muscle injury preceded the intervention. For elective coronary angioplasty and stenting performed for stable angina, where the procedure was planned rather than emergency, and where the heart muscle is not significantly damaged, the recovery is typically straightforward. Most patients are discharged from Hridhay Heart Center the same day or the morning after the procedure. The wrist access site is closed with a compression band that is removed over several hours. Light activity can be resumed promptly: walking, light household tasks, and sitting at a desk are appropriate from the day after discharge. Most patients performing sedentary or desk-based work can return within one to two weeks. Physical work that involves lifting, carrying, or sustained exertion requires a longer recovery and should be discussed individually based on the extent of coronary disease treated and the heart's overall function. Driving: for private use, most patients can resume driving one to two weeks after elective stenting once they are comfortable turning the steering wheel without wrist discomfort and once their symptoms have settled. For commercial vehicle drivers or those whose licence category has specific medical requirements, the regulations differ and the relevant authority must be notified of the cardiac procedure. For patients who have had a heart attack before or alongside the stenting procedure, the recovery timeline is longer and depends substantially on how much heart muscle was affected. A small heart attack with preserved heart function may allow return to light work within two to four weeks. A large heart attack that has reduced the heart's pumping capacity requires a more extended recovery, formal cardiac rehabilitation, and reassessment of function before return to any demanding work. The practical guidance I give every patient at Hridhay Heart Center is to use how you feel at a given activity as your guide, to not push through chest discomfort or breathlessness, and to contact me at any stage if you are unsure whether what you are experiencing is expected or needs assessment.

Rotablation, or rotational atherectomy, is a technique used in interventional cardiology to modify coronary plaques that are so heavily calcified that standard balloon inflation cannot adequately expand them. Understanding why this matters requires understanding what calcification does to a coronary plaque. In a heavily calcified lesion, the plaque contains deposits of calcium that give the arterial wall the consistency of eggshell rather than the pliable tissue of a normal artery. When a standard angioplasty balloon is inflated inside such a vessel, the calcium does not yield: the balloon either inflates in the softer non-calcified segments of the plaque, creating an uneven expansion, or cannot be inflated to the pressure required for full expansion at all. The result is an incompletely expanded stent, which sits unevenly in the vessel, is at higher risk of stent thrombosis and restenosis, and does not perform with the effectiveness that a properly expanded drug-eluting stent delivers. Rotablation solves this problem by modifying the calcium before the balloon and stent are delivered. A rotablation system uses a diamond-tipped burr mounted on a drive shaft, spinning at up to 200,000 revolutions per minute, that is advanced over the coronary guidewire to the calcified lesion and passed through it. The diamond-tipped burr ablates the calcium, converting the rigid calcified plaque into a surface that can be adequately dilated by a balloon and fully expanded by a stent. It does not remove all the plaque, but it modifies the calcium structure sufficiently to allow the stent to expand to its full intended diameter and embed evenly in the vessel wall. The clinical significance of this is that many patients who have been told their coronary disease is too calcified to be treated by stenting, and who have therefore been excluded from less invasive treatment, can in fact be treated by PCI with rotablation, restoring blood flow without the need for bypass surgery. At Hridhay Heart Center, Gajuwaka, Visakhapatnam, rotablation is available as part of the complex coronary intervention programme, and patients referred from across Andhra Pradesh with apparently untreatable calcified coronary disease have been successfully treated here without needing to travel to a metropolitan centre.

Related reading: 

Coronary angiography is a procedure that patients anticipate with considerable anxiety, and one of the most useful things I can do for a patient who is about to undergo it at Hridhay Heart Center, Gajuwaka, is give them an honest account of what they will experience. The procedure is performed with the patient awake but sedated enough to be relaxed. The access site is the wrist: the skin over the radial artery is numbed with a small injection of local anaesthetic, which produces a brief stinging sensation that is similar to having a blood test. After the skin is numb, the introducer sheath is placed into the artery painlessly. The catheter is then advanced from the wrist through the arterial system to the heart under real-time X-ray guidance. The patient feels none of this: there are no pain receptors inside the blood vessels or the heart, and the catheter's passage from the wrist to the coronary arteries is entirely without sensation. The only sensation during the procedure itself is a brief flush of warmth that occurs when the contrast material is injected into the coronary arteries, which some patients notice and others do not. The procedure from start to finish takes approximately 30 to 45 minutes. After the procedure, the wrist sheath is removed and a small compression band is placed over the access site, which is worn for several hours. Most patients are able to sit up, eat, and drink within an hour of the procedure, and in elective cases many patients are discharged the same day or the morning after. The wrist access route has replaced the groin route as the standard approach because it is substantially more comfortable after the procedure, allows earlier mobilisation, and has a lower risk of access site complications. For the vast majority of patients, coronary angiography at Hridhay Heart Center is far less frightening in reality than the anticipation of it beforehand.

Related reading: 

Understanding the risk factors for coronary artery disease is the foundation of both preventing it in people who do not yet have it and slowing its progression in those who do. Risk factors divide into those that cannot be changed and those that can. The non-modifiable factors are age, sex (men develop coronary artery disease earlier than women on average, though women's risk rises sharply after menopause), a family history of premature coronary artery disease in a first-degree relative before the age of 55 in men or 65 in women, and prior coronary events. These factors cannot be changed, but they tell us who needs the most aggressive management of the modifiable factors. The modifiable factors are where the clinical opportunity lies. High LDL cholesterol drives the atherosclerotic process directly: LDL particles penetrate the arterial wall, oxidise, trigger inflammation, and accumulate as plaque. Reducing LDL with high-intensity statin therapy is the most evidence-supported pharmacological intervention in coronary artery disease. High blood pressure exerts continuous mechanical stress on the arterial endothelium, accelerating the sites of endothelial injury at which plaque formation begins: controlling blood pressure to below 130 by 80 mmHg significantly reduces cardiovascular risk. Type 2 diabetes accelerates atherosclerosis through multiple mechanisms and in my clinical research on patients presenting with acute coronary syndrome at Hridhay Heart Center, Gajuwaka, Visakhapatnam, I have specifically studied the relationship between HbA1c levels and coronary event outcomes: the Visakhapatnam population has a very high prevalence of type 2 diabetes, and silent coronary disease in this group is a consistent clinical challenge. Smoking is the most powerful single modifiable risk factor: its cessation produces a 50 percent reduction in recurrent coronary event risk within one year. Physical inactivity, obesity, and chronic psychological stress all contribute and all respond to lifestyle intervention. The most important clinical message is that modifiable risk factors compound each other: a patient who has elevated LDL, high blood pressure, diabetes, and smokes does not have four separate risks but a multiplicatively higher risk than any individual factor alone, and addressing all of them is what determines long-term cardiac health.